Skip to main content
Caplight Logo









LightChain Capital

LightChain Capital

Saint Louis, Michiganlightchain-capital.com

Overview

LightChain Capital is a venture capital firm and family office that invests primarily in early-stage life sciences and software companies, with a focus on advancing treatments for multiple myeloma and related cancers.

Year Founded

2018

Portfolio Companies

14

Investments

LightChain Capital investments
CompanyDateStageLead
C4 TherapeuticsJun 2020Series BCo-investor
NextRNA TherapeuticsMar 2022Series ALead
Predicta BiosciencesOct 2025Series ACo-investor
Allotera TherapeuticsJul 2026Series C ExtensionCo-investor
GeneoscopyJan 2025Series CCo-investor
Book a demo to see all 14 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is LightChain Capital based?

LightChain Capital is headquartered in Saint Louis, Michigan, United States.

When was LightChain Capital founded?

LightChain Capital was founded in 2018.

How many portfolio companies does LightChain Capital have?

LightChain Capital has 14 portfolio companies in Caplight's dataset.

What are some companies in LightChain Capital's portfolio?

Portfolio companies visible on Caplight include C4 Therapeutics, NextRNA Therapeutics, Predicta Biosciences, Allotera Therapeutics, Geneoscopy.

What was LightChain Capital's most recent investment shown here?

LightChain Capital's most recent investment in this portfolio sample was in Allotera Therapeutics in 2026.

What sectors does LightChain Capital focus on?

LightChain Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, FinTech, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure.

What company stages does LightChain Capital focus on?

LightChain Capital typically invests at the MultiStage stage.

What is LightChain Capital's AUM?

LightChain Capital's assets under management are estimated between $50.0M and $100.0M.

Firmographic Details

HeadquartersSaint Louis, Michigan
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?